TG Therapeutics Inc ULTIMATE I & II Phase 3 Investor & Analyst Webcast Transcript
Ladies and gentlemen, thank you for standing by. Greetings, and welcome to the TG Therapeutics webinar.
(Operator Instructions)
As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Jenna Bosco. Please go ahead.
Good morning, everyone, and thank you all for joining us. My name is Jenna Bosco, and I'm Head of Corporate communication for TG Therapeutics. And we're very excited to share with you all today a preview of the ULTIMATE I and II Phase III trial results.
Before we begin, I just want to remind everyone that we anticipate making some forward-looking statements based on our current expectations. These statements involve risks and uncertainties that can cause our actual results to differ materially. For a description of these risks and uncertainties, we encourage you to review the disclosures on this slide and also in our latest reports filed with the Securities and Exchange Commission and available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |